CVS Health rebounds in 2025 with shares up 50% after a rough 2024. Click here to read what leads to an upgraded rating from ...

Buy rating initiated! Discover why this medtech leader with strong growth prospects & dividends is worth your attention.

Snacks maker Monde Nissin Corp. will spend this year P7.5 billion, which will mostly go to a new biscuit plant and to boost ...